Artificial Intelligence in Diabetes Management
Artificial Intelligence in Diabetes Management Market by Product Type (Devices, Solutions), End User (Clinics, Diabetes Research Institutes, Homecare Settings) - Global Forecast 2025-2030
SKU
MRR-4369010656EF
Region
Global
Publication Date
February 2025
Delivery
Immediate
2024
USD 1.00 billion
2025
USD 1.32 billion
2030
USD 5.04 billion
CAGR
30.79%

The Artificial Intelligence in Diabetes Management Market size was estimated at USD 1.00 billion in 2024 and expected to reach USD 1.32 billion in 2025, at a CAGR 30.79% to reach USD 5.04 billion by 2030.

Artificial Intelligence in Diabetes Management Market
To learn more about this report, request a free PDF copy

Artificial Intelligence (AI) in diabetes management encompasses tools and solutions designed to enhance the diagnosis, monitoring, and treatment of diabetes through advanced AI technologies like machine learning, predictive analytics, and natural language processing. The necessity for AI in this sector arises from the increasing prevalence of diabetes globally, the demand for personalized treatment plans, and the need for efficient data management in healthcare systems. AI applications in diabetes management include glucose monitoring systems, AI-powered insulin delivery devices, predictive algorithms for diabetes complications, and virtual coaching platforms. The end-use scope primarily involves healthcare providers, patients, research institutes, and pharmaceutical companies. Key growth factors in this market include technological advancements in AI, an increase in patient awareness, supportive government initiatives, and collaborations among tech firms and healthcare providers. Current market opportunities include the development of AI-driven wearable devices, integration of AI with electronic health record systems, and expansion into telehealth services. To capitalize on these, companies should invest in R&D for more accurate predictive algorithms and real-time monitoring solutions. However, market growth faces challenges such as data privacy concerns, high costs of AI deployment, and the need for standardized regulations. Furthermore, the complexity of diabetes management requires interdisciplinary expertise, making integration difficult. Innovations are best focused on enhancing the interoperability between AI tools and existing healthcare infrastructures, scalable AI models that can handle diverse datasets, and user-friendly patient interfaces. The nature of the market is dynamic and competitive, characterized by rapid technological innovations and shifting consumer awareness. AI in diabetes management is poised for significant growth, promising better patient outcomes and streamlined healthcare processes, but addressing these challenges requires strategic partnerships and a focus on ethical AI practices.

Ask ResearchAI anything

World's First Innovative Al for Market Research

Ask your question about the Artificial Intelligence in Diabetes Management market, and ResearchAI will deliver precise answers.
How ResearchAI Enhances the Value of Your Research
ResearchAI-as-a-Service
Gain reliable, real-time access to a responsible AI platform tailored to meet all your research requirements.
24/7/365 Accessibility
Receive quick answers anytime, anywhere, so you’re always informed.
Maximize Research Value
Gain credits to improve your findings, complemented by comprehensive post-sales support.
Multi Language Support
Use the platform in your preferred language for a more comfortable experience.
Stay Competitive
Use AI insights to boost decision-making and join the research revolution at no extra cost.
Time and Effort Savings
Simplify your research process by reducing the waiting time for analyst interactions in traditional methods.

Market Dynamics

The market dynamics represent an ever-changing landscape of the Artificial Intelligence in Diabetes Management Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Primary incentives motivating the healthcare industry to embrace AI for advanced diabetes control
    • Significant trends increasing the utilization of AI innovations to optimize diabetes care strategies
    • Driving factors enhancing the reliance on artificial intelligence for effective diabetes management
  • Market Restraints
    • Factors contributing to limited scalability of AI-driven systems in diabetes management
    • Lack of awareness and understanding restricting the growth of AI innovations in diabetes treatment
    • Potential barriers preventing widespread acceptance of AI in managing diabetes healthcare tools
  • Market Opportunities
    • Predictive analytics driven by AI can improve detection and diagnosis rates among high-risk populations
    • AI algorithms can optimize personalization in diabetes treatment plans for improved patient outcomes
    • AI-driven research platforms can expedite novel drug discovery and therapeutic solutions for diabetes
  • Market Challenges
    • Overcoming regulatory barriers in implementing AI technologies within diabetes treatment protocols
    • Minimizing technical skill gaps in healthcare personnel for effective AI utilization in diabetes care
    • Analyzing resistance to change from traditional to AI-enabled methodologies in diabetes management

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Artificial Intelligence in Diabetes Management Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

PESTLE Analysis

The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Artificial Intelligence in Diabetes Management Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Artificial Intelligence in Diabetes Management Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Artificial Intelligence in Diabetes Management Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Artificial Intelligence in Diabetes Management Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Diabetes Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bigfoot Biomedical, Inc., Cardinal Health Inc., Crayon Group, DreaMed Diabetes, Ltd., Eyenuk, Inc., F. Hoffmann-La Roche Ltd., Glooko SAS, HCL Technologies Limited, International Business Machines Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Virta Health Corp., and Vodafone Group PLC.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Diabetes Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Devices
      • Continuous Glucose Monitors
      • Insulin Pumps
      • Smart Insulin Pens
    • Solutions
      • AI-Powered Algorithms
        • Personalized Therapy Recommendations
      • Data Analytics Platforms
      • Predictive Analytics
  • End User
    • Clinics
    • Diabetes Research Institutes
    • Homecare Settings
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Artificial Intelligence in Diabetes Management Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Artificial Intelligence in Diabetes Management Market, by Product Type
  7. Artificial Intelligence in Diabetes Management Market, by End User
  8. Americas Artificial Intelligence in Diabetes Management Market
  9. Asia-Pacific Artificial Intelligence in Diabetes Management Market
  10. Europe, Middle East & Africa Artificial Intelligence in Diabetes Management Market
  11. Competitive Landscape
  12. List of Figures [Total: 21]
  13. List of Tables [Total: 235 ]
  14. List of Companies Mentioned [Total: 15]
360iResearch Analyst Ketan Rohom
Download a Free PDF
Get a sneak peek into the valuable insights and in-depth analysis featured in our comprehensive artificial intelligence in diabetes management market report. Download now to stay ahead in the industry! Need more tailored information? Ketan is here to help you find exactly what you need.
Frequently Asked Questions
  1. How big is the Artificial Intelligence in Diabetes Management Market?
    Ans. The Global Artificial Intelligence in Diabetes Management Market size was estimated at USD 1.00 billion in 2024 and expected to reach USD 1.32 billion in 2025.
  2. What is the Artificial Intelligence in Diabetes Management Market growth?
    Ans. The Global Artificial Intelligence in Diabetes Management Market to grow USD 5.04 billion by 2030, at a CAGR of 30.79%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.